​Multinational biopharmaceutical company.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | TODD STRATEGY GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | TODD STRATEGY GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | TODD STRATEGY GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | TODD STRATEGY GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | TODD STRATEGY GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2024 | TODD STRATEGY GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2024 | TODD STRATEGY GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | TODD STRATEGY GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | TODD STRATEGY GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2023 | TODD STRATEGY GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| TODD STRATEGY GROUP | 30 | — |
| Issue | Activities |
|---|---|
| Health Issues | 27 |
| Pharmacy | 16 |
| Medicare/Medicaid | 14 |
| Trade (domestic/foreign) | 3 |
| Tariff (miscellaneous tariff bills) | 1 |